Anthony Bosco

Dr. Bosco was born in 1978 and raised near Fremantle, Western Australia. After completing his undergraduate studies, he worked as a research assistant in Patrick G. Holt’s laboratory at the Telethon Kids Institute for 1.5 years before enrolling in a PhD program in the Holt lab to study immunology and genomics. After completing his postdoctoral training with Fernando D. Martinez at the Arizona Respiratory Center, the leading center for pediatric asthma in the US, he returned to the Telethon Kids Institute in Perth in 2011 where he built the Systems Immunology program over the next 11 years. In October 2021, he co-founded a startup company called Respiradigm Pty Ltd. Respiradigm is developing technologies to predict at birth the propensity for a child to develop asthma. This technology will enable parents to take pre-emptive action to minimize the risk of asthma developing in their child. In November 2021, he founded a new data science startup, INSiGENe Pty Ltd. The value proposition of INSiGENe is the GENesis of actionable INSights to unlock disease and novel therapies. In December 2021, he relocated to the University of Arizona.